111. Eltabbakh GH, Charboneau AM, Eltabbakh NG. Laparoscopic Surgery for large ovarian cysts. Gynecol Oncol (in press).

110. Eltabbakh GE, Broad ligament lipoma presenting as a pelvic mass. J Reprod Med (in press).

109. Eltabbakh GH, Goodrich ST. Update on the management of women with recurrent ovarian cancer. Women's Health 2006;2(1)(in press).

108. Eltabbakh GE, Mount SL. Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma. Gynecol Oncol (in press).

107. Eltabbakh GE, Shamonki J, Mount SL. Surgical stage, final grade and survival of women with endometrial carcinoma whose pre-operative endometrial biopsy shows well-differentiated tumors. Gynecol Oncol (in press).

106. Mount SL, Eltabbakh GE, Simmons-Arnold L, Wong C, Cooper K. Mullerian and mesothelial lymph node involvement in patients with ovarian borderline tumors. Submitted for publication.

105. Eltabbakh GH, Mount SL, Beatty B, Simmons-Arnold L, Wong C, Cooper K. Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma. J Surgical Oncology (in press).

104. Mount SL, Harmon M, Eltabbakh GH, Uyar D. False-positive diagnosis in conventional and liquid-based cervical specimins. Acta Cytol 2004;48:363-71.

103. Eltabbakh GH. Recent advances in the management of women with ovarian cancer. Minerva Ginecol 2004;56(1):81-9.

102. Eltabbakh GH, Yildirim Z, Adamowicz R. Paclitaxel and Carboplatin as second-line therapy in women with platinum-sensitive ovarian carcinoma treated with platinum and paclitaxel as first-line therapy. Am J Clin Oncol 2004;27(1):46-50.

101. Eltabbakh GH, Mount SL, Beatty B, Simmons-Arnold L, Cooper K, Morgan A. Factors associated with cytoreducability among women with ovarian carcinoma. Gynecol Oncol 2004;95:377-83.

100. Mount SL, Eltabbakh GE, Cooper K. Recent non-gynaecological immunohistochemical markers in diagnostic ovarian pathology. Current Diag Pathol 2003;9:11-18.

99. Eltabbakh GH. Laparoscopic management of ovarian cysts. Contemporary OB/GYN, august 2003;37-50.

98. Padmanabhan V, Mount SL, Eltabbakh GH. Peritoneal atypical mesothelial proliferation with progression to invasive mesothelioma: a case report and review of the literature. %0D%0Apathology 2003;35(3):260-3.

97. Uyar DS,Eltabbakh GH, Mount SL. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. Gynecol Oncol 2003;89(2):227-32.

96. Wong C, Plante M, Eltabbakh GH. Synchronous renal cell carcinoma and gynecologic malignancies. Gynecol Oncol 2003;88(1):66-8

95. Mount SL, Wegner EK, Eltabbakh GH, Olmsted JI, Drejet AE. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy. Obstet Gynecol 2002;100(3):445-50.

94. Eltabbakh GH, Mount SL. Lymphatic spread among women with primary peritoneal carcinoma. J Surg Oncol 2002;81(3):126-31.

93. Eltabbakh GH. Analysis of survival following laparoscopic management of women with endometrial carcinoma. Cancer 2002;95(9):1894-901.

92. Duska LR, Garrett A, Eltabbakh GH, Oliva E, Penson R., Fuller AF. Paclitaxel and platinum chemotherapy for malignant mixed mullerian tumor of the ovary. Gynecol Oncol 2002;85(3):459-63.

91. Mount SL, Eltabbakh GH, Hardin NJ. Beta-2 microglobulin amyloidosis presenting as bilateral ovarian masses: A case report and review of the literature. Am J Surg Pathol 2002;26(1):130-3.

90. Padmanabhan V, Mount SL, Eltabbakh GH. Cavernous hemangioma of the cervix uteri in association with focal nodular hyperplasia of the liver. A case report and review of the literature. J Reprod Med 2001;46:1067-70.

89. Eltabbakh GH, Wong C. Lymphadenectomy in the management of women with endometrial carcinoma: Potential benefits and risks (Commentary). J Surg Oncol 2001;78:237-40.

88. Dodge JA, Eltabbakh GH, Mount SL, Walker RP, Morgan A. Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol 2001;83:363-9.

87. Eltabbakh GH, Mount SL. Tamoxifen and the female reproductive tract. Exp Opin Pharmacother 2001;2(9):1-15.

86. Chamberlin MD, Eltabbakh GH, Mount SL, Leavitt BJ. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: A case report and review of the literature. Gynecol Oncol 2001;82:212-5.

85. Eltabbakh GH, Mount SL. Comparison of diaphragmatic wash and scrape specimens in staging of women with ovarian cancer. Gynecol Oncol 2001;81:461-5.

84. Eltabbakh GH. Intraoperative clinical evaluation of lymph nodes in women with gynecologic cancer. Am J Obstet Gynecol 2001;184:1177-81.

83. Werness BA, Eltabbakh GH. Familial ovarian cancer and early ovarian cancer: Biologic, pathologic and clinical features. Int J Gynecol Pathol 2001;20:48-63.

82. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma. Cancer 2001;91(2):378-87.

81. Eltabbakh GH, Awtrey CS. Current treatment for ovarian cancer. Exp Opin Pharmacother 2001;2(1):109-24.

80. Eltabbakh GH, Natarajan N, Piver MS, Mettlin CJ. Epidemiologic differences between women with colorectal cancer and women with ovarian cancer. J Surg Oncol 2001;76:283-8.

79. Eltabbakh GH, Lipman JN, Mount SL, Morgan A. Significance of atypical squamous cells of undetermined significance on ThinPrep Papanicolaou smears. Gynecol Oncol 2000;79:44-9.

78. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy? Gynecol Oncol 2000;78:329-35.

77. Eltabbakh GH, Lipman JN, Mount SL, Morgan A. Significance of atypical glandular cells of undetermined significance on ThinPrep Papanicolaou smears. Gynecol Oncol 2000;78:245-50.

76. Werness BA, Eltabbakh GH. Ovarian dysplasia identified by cul-de-sac aspiration: a reexamination of previously reported cases. Int J Gynecol Pathol 2000;19(2):190-1.

75. Eltabbakh GH. Effect of surgeon's experience on the surgical outcome of laparoscopic surgery for women with endometrial cancer. Gynecol Oncol 2000;78:58-61.

74. Eltabbakh GH. Extreme drug resistance assay and response to chemotherapy in patients with primary peritoneal carcinoma. J Surg Oncol 2000;73:148-52.

73. Eltabbakh GH, Kaiser J. Laparoscopic management of a large ovarian cyst in an adolescent: A case report. J Reprod Med 2000;45:231-4.

72. Eltabbakh GH, Srivastava A, Garafano LL. Surgical response of advanced stage borderline ovarian tumors to paclitaxel and cisplatin chemotherapy. Gynecol Oncol 2000;77:343-4.

71. Eltabbakh GH, Awtrey CS, Walker P. Adult respiratory distress syndrome following extensive cytoreductive surgery. J Reprod Med 2000;45:51-4.

70. Eltabbakh GH, Field JM, Trask CE, McDay JB, Swift PD. Primary vaginal squamous cell carcinoma presenting as a cystic pelvic mass. Gynecol Oncol 2000;76:213-7.

69. Eltabbakh GH, Trask CE. Scrape cytology for intraoperative evaluation of lymph nodes in gynecologic cancer. Obstet Gynecol 2000;95:67-71.

68. Mensch L,Trask CE, Eltabbakh GH. Leiomyosarcoma of the vulva: A brief communication. Eur J Gynecol Oncol 2000;XXI(1); 61.

67. Werness BA, Afify AM, Eltabbakh GH, Huelsman K, Piver MS, Paterson JM. p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer. Int J Gynecol Pathol 1999;18(4):338-43.

66. Piver MS, Ghamande SA, Eltabbakh GH, O'Neill-Coppola C. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix %96 A phase II study. Gyecol Oncol 1999;75:334-7.

65. Eltabbakh GH, Yadev PR, Morgan A. Clinical picture of women with early stage ovarian cancer. Gynecol Oncol 1999;75:476-9.

64. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Paczos T. Laparoscopic management of women with a family history of ovarian cancer. J Surg Oncol 1999;72:9-13.

63. Eltabbakh GH, Yadav PR. Good response of malignant mixed mullerian tumor of the ovary to paclitaxel and cisplatin chemotherapy. Europ J Gynecol Oncol 1999;XX(5):355-6.

62. Eltabbakh GH. Small bowel herniation through a 5 mm laparoscopic trocar site following pelvic lymphadenectomy. Europ J Gynecol Oncol 1999;XX(4):275-6.

61. Eltabbakh GH. Extreme drug resistance assay in women with ovarian cancer (Letter to the Editor). Gynecol Oncol 1999;74:149-50.

60. Eltabbakh GH, Piver MS. Concerns with maintenance chemotherapy in women with recurrent ovarian cancer (Letter to the Editor). Gynecol Oncol 1999;73: 470-2.

59. Eltabbakh GH, Piver MS, Hempling RE, Recio FO. Laparoscopic surgery in obese women. Obstet Gynecol 1999;94:704-8.

58. Eltabbakh GH, Piver MS, Hempling RE, Recio FO. Analysis of failed and complicated operative laparoscopy on a gynecologic oncology service. Gynecol Oncol 1999;74:477-82.

57. Eltabbakh GH, Natrajan N, Piver MS, Mettlin CJ. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecol Oncol 1999;74:103-7.

56. Eltabbakh GH, Moore AD. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 1999;74:80-5.

55. Eltabbakh GH, Eltabbakh GD. Pap smear: How can we make a good test better? Technical and interpretive challenges for the practitioner. J Women's Health and Gender-Based Med 1999;8:469-76.

54. Eltabbakh GH, Moody J, Garafano LL, Hammond JM. The combination paclitaxel, carboplatin and megesterol acetate is effective in women with recurrent uterine papillary serous adenocarcinoma. Europ J Gynecol Oncol 1999;XX(1):18-9.

53. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME. Clinical picture, response to therapy and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999;70:6-12.

52. Werness BA, Afify AM, Bielat KL, Eltabbakh GH, Piver MS, Patterson JM. Altered surface epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum Pathol 1999;30:151-7.

51. Eltabbakh GH, Piver MS. Ovarian Cancer: The myths and the facts. Quality of Life: A Nursing Challenge 1998;6(6): 83-87.

50. Silver DF, Hempling RE, Piver MS, Recio FO, Eltabbakh GH. Stage I adenocarcinoma of the cervix: Does lesion size affect treatment options and prognosis? Am J Clin Oncol 1998;21:431-5.

49. Silver DF, Hempling RE, Recio FO, Piver MS, Eltabbakh GH. Complications related to indwelling caval catheters on a gynecologic oncology service. Gynecol Oncol 1998;70:329-33.

48. Hempling RE, Piver MS, Eltabbakh GH, Recio FO. Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer. Am J Clin Oncol 1998;21:447-51.

47. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Blumenson LE. Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol 1998;71:190-5.

46. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Lele SB, Marchetti DL, Baker TR, Blumenson LE. Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer. Gynecol Oncol 1998;70:392-7.

45. Eltabbakh GH, Werness BA, Piver MS, Blumenson LE. Prognostic factors in extra ovarian primary peritoneal carcinoma. Gynecol Oncol 1998;71:230-9.

44. Eltabbakh GH, Piver MS. Extraovarian primary peritoneal carcinoma. Oncology 1998;12:813-9.

43. Eltabbakh GH, Piver MS, Hempling RE, Werness BA, Blumenson LE. Importance of lymph node metastases in primary peritoneal carcinoma. J Surg Oncol 1998;68:144-8.

42. Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS. The clinical value of hybrid capture HPV DNA testing in a referral-based population with abnormal Pap smears. Europ J Gynecol Oncol 1998; 19:203-8.

41. Eltabbakh GH, Piver MS, Natarajan N, Metlin CM. Epidemiological difference between women with extra-ovarian primary peritoneal carcinoma and women with ovarian cancer. Obstet Gynecol 1998;91:254-9.

40. Eltabbakh GH, Hempling RE, Recio FO, O'Neill CP. Remarkable response of primary squamous cell carcinoma of the ovary to paclitaxel and cisplatin (Case Report). Obstet Gynecol 1998;91:844-6.

39. Recio FO, Piver MS, Hempling RE, Eltabbakh GH, Hahn S. Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study. Int J Radiat Oncol Biol Phys 1998;40:411-4.

38. Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Bluemenson L. Prospective sequential trials comparing induction weekly cisplatin followed by monthly cisplatin, adriamycin, cyclophosphamide and paclitaxel and cisplatin in optimal (< 1 cm) stage III and IV ovarian cancer. Europ J Gynecol Oncol 1998;19:5-10.

37. Eltabbakh GH. Review Article: Telomerase in gynecologic cancers. Obstet Gynecol 1997;90:1015-9.

36. Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Bluemenson L. Two sequential studies for primary peritoneal carcinoma: Induction with weekly cisplatin followed by either cisplatin- adriamycin-cyclophosphamide or by paclitaxel-cisplatin. Gynecol Oncol 1997;67: 141-6.

35. Loree T, Hempling RE, Eltabbakh GH, Recio FO, Piver MS. The inferior gluteal flap in the difficult vulvar and perineal reconstruction. Gynecol Oncol 1997;66: 429-34.

34. Eltabbakh GH, Piver MS, Werness BA. Primary peritoneal adenocarcinoma metastatic to the brain. Gynecol Oncol 1997;66:160-3.

33. Eltabbakh GH, Piver MS, Hempling RE, Shin K. Excellent long-term survival and absence of vaginal recurrence in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy without formal staging lymphadenectomy and postoperative vaginal brachytherapy. Report of a prospective study. Int J Radiat Oncol Biol Phys, 1997; 38:373-80.

32. Eltabbakh GH, Belinosn JL, Kennedy AW, Biscotti CV, Casey G, Tubbs R. p53 overexpression is not an independent prognostic variable in patients with epithelial ovarian cancer. Cancer 1997;80:892-8.

31. Eltabbakh GH, Belinson JL, Kennedy AW, Gupta M, Webster K, Blumenson L. Serum CA-125 measurements greater than 65 U/mL. Clinical value. J Reprod Med 1997;42:617-24.

30. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Aiduk C. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer. Gynecol Oncol 1997;66:103-7.

29. Hempling RE, Eltabbakh GH, Piver MS, Recio FO, O'Neill CP. The addition of bleomycin and dose escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma. Am J Clin Oncol 1997;20(3):315-8.

28. Eltabbakh GH, Belinson JL, Kennedy AW, Biscotti CV, Casey G, Tubbs R. p53 and HER-2/neu overexpression in ovarian borderline tumors. Gynecol Oncol 1997; 65:218-24.

27. Eltabbakh GH, Belinson JL, Biscotti CV. Osteosarcoma metastatic to the ovary. A case report and review of the literature. Int J Gynecol Pathol 1997;16:76-8.

26. Eltabbakh GH, Gupta M, Belinson JL, Kennedy AW, Webster K , Parisio MF. Comparison between Centcor CA-125 and CA-125 II assays. Eur J Gynecol Oncol 1996;17(6):504-6.

25. Eltabbakh GH, Watson JD. Postpartum hysterectomy. Int J Gynecol Obstet 1995; 50: 257-62.

24. Kennedy AW, Eltabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995; 58:274-7.

23. Eltabbakh GH, Hoogerland DL, Kay MC. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol 1995; 58:120-3.

22. Eltabbakh GH, Walters MD. Secondary closure of superficial wound dehiscence. J Pelvic Surgery 1995; 1: 210-3.

21. Eltabbakh GH, Eltabbakh GD, Broekhuizen FF, Griner BT. Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women. Obstet Gynecol 1995; 85:449-503.

20. Eltabbakh GH, Samter GT. Sex cord tumors of the uterus. Int J Gynecol Obstet 1995; 48:113-4.

19. Eltabbakh GH, Elejalde BR, Broekhuizen FF. Primary syphilis and nonimmune fetal hydrops in a penicillin-allergic woman. A case report. J Reprod Med 1994; 39:412-4.

18. Eltabbakh GH, Broekhuizen FF. Spontaneous quadruplet pregnancy in a woman with a personal and family history of spontaneous twin and triplet pregnancy. A case report. J Reprod Med 1994; 39:134-6.

17. Thomason JL, Gelbart SM, Osypowski PJ, Scaglione NJ, Eltabbakh GH, James JA. Simplified gram stain interpretative method for diagnosis of bacterial vaginosis. Am J Obstet Gynecol 1992; 167:16-9.

16. Eltabbakh GH, Darwish E, El Sebai F, Galal S, El Marad E, Loutfi IA. Study of the serum copper and zinc in cases of hyperemesis gravidarum. Int J Gynecol Obstet 1989; 29:263-8.

15. Eltabbakh GH, Hamza MA. Carcinoma of the uterine cervix and schistosomiasis. Int J Gynecol Obstet 1989; 29:207-13.

14. Eltabbakh GH, Loutfi IA, Azab I, Rahman HA, Southren AL, Aleem FA. Bromocriptine in polycystic ovarian disease: a controlled clinical trial. Obstet Gynecol 1988; 7:301-6.

13. Souka AR, Sallam H, Zeitoun K, Eltabbakh GH, Abul-Einin M. Hormone levels in early morning urine during clomiphene cycles. J Obstet Gynaecol 1988; 9:68-75.

12. Enein M, Abou Zina AA, Kassem M, Eltabbakh GH. Echocardiography of the pericardium in pregnancy. Obstet Gynecol 1987; 69:851-3.

11. Eltabbakh GH, Loutfi IA, Azab I, Rahman HA, Aleem FA, Southren AL. A controlled clinical study for the effect of bromocriptine on the adrenal contribution in polycystic ovarian disease. Acta Endocrinol 1987; 1145(2):161-5.

10. Eltabbakh GH, El Sayed OK, Hamza MA. Immunohistochemical and quantitative estimation of beta endorphin in polycystic ovarian disease. Asia-Oceania J Obstet Gynecol 1987; 13(4):485-8.

9. Omar RA, Eltabbakh GH. Immunoreactive beta endorphin in ovarian sex cord stromal tumors. Arch Path Lab Med 1987; 111:436-9.

8. Nayel S, Zahran M, Abdel Gawad A, Mokhtar A, Gawish S, Eltabbakh GH. Serum nickel in normal menstrual cycle and after combined contraceptive pills. Contraception 1987; 34(4): 395-401.

7. Aleem FA, Eltabbakh GH, Omar RA, Southren AL. Ovarian follicular fluid beta endorphin levels in normal and polycystic ovaries. Am J Obstet Gynecol 1987; 156:1197-200.

6. Eltabbakh GH, Lotfy I, Azab I, Rahman HA, Southren AL, Aleem FA. Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal and laparoscopic findings. Am J Obstet Gynecol 1986; 154:892-5.

5. Aleem FA, Omar RA, Eltabbakh GH. Immunoreactive beta endorphin in human ovaries. Fertil Steril 1986, 45(4):507-11.

4. Abul Enin MA, Saleh FM, Eltabbakh GH, Zaki YH. Ultrasonography and missed threads of intrauterine contraceptive devices. Contraceptive Deliv Syst 1984; 5:25-8.

3. El-Sahwi S, Gaweesh S, Abdel-Aal, Onayiga O, Eltabbakh GH, Gawad AA. Effect of intravenous oxytocin on maternal and fetal electrolyte levels. Bulletin Alexandria Faculty of Medicine 1987; 23(2): 385-90.

2. Gawesh S, Morad A, Ramzi HN, Gazaierly S, Eltabbakh GH. Anaerobic infection after gynecologic and obstetric operations. A clinico bacteriologic study. Bulletin Alexandria Faculty of Medicine 1986; 22(4): 1109-14.

1. Abul-Enin MA, Saleh FM, Abel-Gawad AH, Eltabbakh GH, Zaki YH. Evaluation of diagnostic ultrasound in gynecology. Bulletin Alexandria Faculty of Medicine 1983; 19(3): 687-96.

Textbooks:

"Myths and Facts About Ovarian Cancer," by M. Steven Piver and Gamal H. Eltabbakh, 1997.

"Alexandria Textbook of Obstetric and Gynecologic Surgery," by Gamal H. Eltabbakh, Publisher: Almarwa, Egypt, 1990.

Chapters in Books:

"c-erbB-2 immunohistochemistry in paraffin tumors," Methods in Molecular Medicine: Ovarian Cancer, 2000.

"Ovarian Cancer", Hematology/Oncology Secrets, third edition, 2003.

Awards and Honors:

Best Doctors in America, 2005- 2009.

Chief Resident Award for Excellence in Teaching, University of Vermont, Department of Obstetrics and Gynecology, 2003-2007.

Examiner for the written exam, American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology, 2002, 2005, 2007.

Ranked in the top 10% among the referees for Obstetrics and Gynecology journal, 2000.

Department of Obstetrics and Gynecology CREOG Excellence in Resident Teaching Award, 1999.

Department of Obstetrics and Gynecology Association of Professors of Gynecology and Obstetrics (APGO) Excellence in Medical Student Teaching Award, 1998.

Best Clinical Report presented by a fellow or a resident, Roswell Park Cancer Institute, Buffalo, New York, 1996.

American Cancer Society Clinical Fellowship, 1996.

Colposcopy Recognition Award presented by the American Society for Colposcopy and Cervical Pathology, 1994.

Phillip R, Hamilton III, M.D. Award for Chief Resident of the Year, University of Wisconsin, Milwaukee, 1994.

Outstanding Resident in OB/GYN Research, University of Wisconsin Medical School, 1994.

Samuel G. Perlson Undergraduate Education Resident Award, University of Wisconsin Medical School, 1993.

Outstanding Resident in Obstetrics and Gynecology Research, University of Wisconsin Medical School, 1992.

Outstanding Presenter at Sinai Samaritan Medical Center's Scientific Day, Milwaukee, 1992.

Doctor Abdel Fatah Youssef Egyptian National Award for Obstetrics and Gynecology Research, Egypt, 1987.

Egyptian Society Youth Physicians’ Award for Outstanding Service, 1986.

Graduation Degree with Honors (top 1% of class), Alexandria University, Egypt, 1978.